Frank, Rimerman Advisors LLC

Position in BMY — Bristol Myers Squibb Co

CIK 1977560 Palo Alto, CA

Position in BMY

as of Jun 30, 2026 · filed Jul 27, 2026 Compact

Position Value

$2,897,709

-$205,508 QoQ

Shares Held

50,290

-1.7% QoQ

Ownership

0.002%

of shares outstanding

% of Portfolio

0.19%

of 13F equity value

Holder Rank

#706

of 2,506 holders

Holding Since

Dec 2023

11 quarters on record

Voting authority Sole 0% Shared 0% None 100%

Healthcare · as of Jun 30, 2026

Frank, Rimerman Advisors LLC holds $61,050,050 across 13 Drug Manufacturers - General names. BMY ranks #7 (4.7% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	LLY	ELI LILLY & Co	11,066	$13,272,893
2	JNJ	Johnson & Johnson	51,668	$13,122,121
3	ABBV	AbbVie Inc.	34,526	$8,688,122
4	MRK	Merck & Co., Inc.	37,710	$4,845,735
5	GILD	Gilead Sciences, Inc.	35,286	$4,458,033
6	PFE	Pfizer Inc	164,115	$3,951,889
7	BMY	Bristol Myers Squibb Co This page	50,290	$2,897,709
8	AMGN	Amgen Inc	7,272	$2,633,336

11 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$2,897,709	50,290	-1.7%	Shares	Sole	2026-07-27
2026-03-31	$3,103,217	51,166	+3.4%	Shares	Sole	2026-04-29
2025-12-31	$2,669,652	49,493	+13.8%	Shares	Sole	2026-01-15
2025-09-30	$1,960,902	43,479	-3.6%	Shares	Sole	2025-11-04
2025-06-30	$2,086,845	45,082	+7.7%	Shares	Sole	2025-08-11
2025-03-31	$2,553,224	41,863	+1.2%	Shares	Sole	2025-05-12
2024-12-31	$2,340,339	41,378	+4.2%	Shares	Sole	2025-02-10
2024-09-30	$2,054,647	39,711	-5.0%	Shares	Sole	2024-10-24
2024-06-30	$1,736,743	41,819	+37238.4%	Shares	Sole	2024-08-13
2024-03-31	$6,073	112	0.0%	Shares	Sole	2024-05-09
2023-12-31	$5,746	112	—	Shares	Sole	2024-02-13
No filing history on record for this holder in this stock.